Abu Dhabi Investment Authority - 04 Feb 2026 SCHEDULE 13G Report for Eikon Therapeutics, Inc. Common Stock, par value $0.0001 per share

Filing Manager: Abu Dhabi Investment Authority
Reporting Manager: Abu Dhabi Investment Authority
Security: Eikon Therapeutics, Inc. Common Stock, par value $0.0001 per share
Shares outstanding: 54,167,577 shares
Disclosed Ownership: 2,816,714 shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Filing time: 18 Feb 2026, 16:16:58 UTC
Date of event: 04 Feb 2026
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Abu Dhabi Investment Authority	5.2%	2,816,714	1,669,576	1,147,138	/s/ Saif Surour Omair Maaded AlMashghouni	Authorized Signatory
Platinum Falcon B 2018 RSC Limited	2.1%	1,147,138	0	1,147,138	/s/ Saif Surour Omair Maaded AlMashghouni	Authorized Signatory